News & Events

June 13, 2024 | SOAR 201910

SOAR 201910 Programme
Conducted by GSK
Active: 2015-2018

Countries: Argentina, Cambodia, Chile, Costa Rica, Kenya, Kuwait, Lebanon, Morocco, Pakistan, Philippines, Saudi Arabia, Singapore, Tunisia, Turkey, Ukraine, Vietnam

Primary objective
To determine antibiotic susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolates from community-acquired respiratory tract infections (CA-RTIs) collected during 2015–18

Isolates collection method:2015-2018 surveillance study frozen stock culture collection.
Isolates of S. pneumoniae and H. influenzae from CA-RTIs (patients with respiratory tract infections in the community, not hospitalized for more than 48h). MICs were determined by CLSI broth microdilution and susceptibility was assessed using CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Includes antibiotics: CDN-Ceftidoren, CEC-Cefaclor, CXM-Cefuroxime, DIN-Cefdinir, FIX-Cefixime
Types of surveillance:Routine clinical practice then used for surveillance.
Methodology and breakpoints:Broth microdilution according to CLSI guidelines.
Reference- CLSI 32 Edition M100 -2022
Date Last Updated31-Dec-2018
Contains pediatric data?Yes
Contains genotype data?No
Number of isolates2318